HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

EPAC1 inhibitor AM-001

Also Known As:

AM-001

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - EPAC1 inhibitor AM-001: 1

Experts

1.	Blondeau, Jean-Paul: 1 article (10/2019)
2.	Coluccia, Antonio: 1 article (10/2019)
3.	Fazal, Loubina: 1 article (10/2019)
4.	Ghaleh, Bijan: 1 article (10/2019)
5.	Laudette, Marion: 1 article (10/2019)
6.	Lezoualc'h, Frank: 1 article (10/2019)
7.	Mialet-Perez, Jeanne: 1 article (10/2019)
8.	Pons, Sandrine: 1 article (10/2019)
9.	Sainte-Marie, Yannis: 1 article (10/2019)
10.	Sicard, Pierre: 1 article (10/2019)

Related Diseases

1.	Inflammation (Inflammations) 10/01/2019 - "Finally, AM-001 attenuates cardiac hypertrophy, inflammation and fibrosis, and improves cardiac function during chronic β-adrenergic receptor activation with isoprenaline (ISO) in mice. "
2.	Hypertrophy 10/01/2019 - "In addition, we found that AM-001 inhibited Epac1-dependent deleterious effects such as cardiomyocyte hypertrophy and death. "
3.	Cardiomegaly (Heart Hypertrophy) 10/01/2019 - "Finally, AM-001 attenuates cardiac hypertrophy, inflammation and fibrosis, and improves cardiac function during chronic β-adrenergic receptor activation with isoprenaline (ISO) in mice. "
4.	Fibrosis (Cirrhosis) 10/01/2019 - "Finally, AM-001 attenuates cardiac hypertrophy, inflammation and fibrosis, and improves cardiac function during chronic β-adrenergic receptor activation with isoprenaline (ISO) in mice. "

Related Drugs and Biologics

1.	Adrenergic Receptors (Adrenergic Receptor)
2.	Isoproterenol (Isoprenaline)